Literature DB >> 25713071

Cyclic AMP signaling reduces sirtuin 6 expression in non-small cell lung cancer cells by promoting ubiquitin-proteasomal degradation via inhibition of the Raf-MEK-ERK (Raf/mitogen-activated extracellular signal-regulated kinase/extracellular signal-regulated kinase) pathway.

Eui-Jun Kim1, Yong-Sung Juhnn2.   

Abstract

The cAMP signaling system regulates various cellular functions, including metabolism, gene expression, and death. Sirtuin 6 (SIRT6) removes acetyl groups from histones and regulates genomic stability and cell viability. We hypothesized that cAMP modulates SIRT6 activity to regulate apoptosis. Therefore, we examined the effects of cAMP signaling on SIRT6 expression and radiation-induced apoptosis in lung cancer cells. cAMP signaling in H1299 and A549 human non-small cell lung cancer cells was activated via the expression of constitutively active Gαs plus treatment with prostaglandin E2 (PGE2), isoproterenol, or forskolin. The expression of sirtuins and signaling molecules were analyzed by Western blotting. Activation of cAMP signaling reduced SIRT6 protein expression in lung cancer cells. cAMP signaling increased the ubiquitination of SIRT6 protein and promoted its degradation. Treatment with MG132 and inhibiting PKA with H89 or with a dominant-negative PKA abolished the cAMP-mediated reduction in SIRT6 levels. Treatment with PGE2 inhibited c-Raf activation by increasing inhibitory phosphorylation at Ser-259 in a PKA-dependent manner, thereby inhibiting downstream MEK-ERK signaling. Inhibiting ERK with inhibitors or with dominant-negative ERKs reduced SIRT6 expression, whereas activation of ERK by constitutively active MEK abolished the SIRT6-depleting effects of PGE2. cAMP signaling also augmented radiation-induced apoptosis in lung cancer cells. This effect was abolished by exogenous expression of SIRT6. It is concluded that cAMP signaling reduces SIRT6 expression by promoting its ubiquitin-proteasome-dependent degradation, a process mediated by the PKA-dependent inhibition of the Raf-MEK-ERK pathway. Reduced SIRT6 expression mediates the augmentation of radiation-induced apoptosis by cAMP signaling in lung cancer cells.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Apoptosis; Cyclic AMP (cAMP); Extracellular Signal-regulated Kinase (ERK); Lung Cancer; Protein Kinase A (PKA); Sirtuin

Mesh:

Substances:

Year:  2015        PMID: 25713071      PMCID: PMC4392263          DOI: 10.1074/jbc.M114.633198

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  41 in total

Review 1.  Developing histone deacetylase inhibitors as anti-cancer therapeutics.

Authors:  B Venugopal; T R J Evans
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

2.  miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling.

Authors:  Alberto Dávalos; Leigh Goedeke; Peter Smibert; Cristina M Ramírez; Nikhil P Warrier; Ursula Andreo; Daniel Cirera-Salinas; Katey Rayner; Uthra Suresh; José Carlos Pastor-Pareja; Enric Esplugues; Edward A Fisher; Luiz O F Penalva; Kathryn J Moore; Yajaira Suárez; Eric C Lai; Carlos Fernández-Hernando
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-16       Impact factor: 11.205

3.  Heterotrimeric stimulatory GTP-binding proteins inhibit cisplatin-induced apoptosis by increasing X-linked inhibitor of apoptosis protein expression in cervical cancer cells.

Authors:  Eun-Ah Cho; Jung-Min Oh; So-Young Kim; Yeni Kim; Yong-Sung Juhnn
Journal:  Cancer Sci       Date:  2011-02-28       Impact factor: 6.716

4.  Global cancer statistics.

Authors:  Ahmedin Jemal; Freddie Bray; Melissa M Center; Jacques Ferlay; Elizabeth Ward; David Forman
Journal:  CA Cancer J Clin       Date:  2011-02-04       Impact factor: 508.702

5.  Identification of a novel biomarker, SEMA5A, for non-small cell lung carcinoma in nonsmoking women.

Authors:  Tzu-Pin Lu; Mong-Hsun Tsai; Jang-Ming Lee; Chung-Ping Hsu; Pei-Chun Chen; Chung-Wu Lin; Jin-Yuan Shih; Pan-Chyr Yang; Chuhsing Kate Hsiao; Liang-Chuan Lai; Eric Y Chuang
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-08-27       Impact factor: 4.254

6.  Mechanisms involved in 3',5'-cyclic adenosine monophosphate-mediated inhibition of the ubiquitin-proteasome system in skeletal muscle.

Authors:  Dawit A P Gonçalves; Eduardo C Lira; Amanda M Baviera; Peirang Cao; Neusa M Zanon; Zoltan Arany; Nathalie Bedard; Preeti Tanksale; Simon S Wing; Stewart H Lecker; Isis C Kettelhut; Luiz C C Navegantes
Journal:  Endocrinology       Date:  2009-10-16       Impact factor: 4.736

7.  Cell cycle-dependent deacetylation of telomeric histone H3 lysine K56 by human SIRT6.

Authors:  Eriko Michishita; Ronald A McCord; Lisa D Boxer; Matthew F Barber; Tao Hong; Or Gozani; Katrin F Chua
Journal:  Cell Cycle       Date:  2009-08-26       Impact factor: 4.534

8.  MDM2-mediated degradation of SIRT6 phosphorylated by AKT1 promotes tumorigenesis and trastuzumab resistance in breast cancer.

Authors:  Umadevi Thirumurthi; Jia Shen; Weiya Xia; Adam M LaBaff; Yongkun Wei; Chia-Wei Li; Wei-Chao Chang; Chung-Hsuan Chen; Hui-Kuan Lin; Dihua Yu; Mien-Chie Hung
Journal:  Sci Signal       Date:  2014-07-29       Impact factor: 8.192

9.  The histone deacetylase Sirt6 regulates glucose homeostasis via Hif1alpha.

Authors:  Lei Zhong; Agustina D'Urso; Debra Toiber; Carlos Sebastian; Ryan E Henry; Douangsone D Vadysirisack; Alexander Guimaraes; Brett Marinelli; Jakob D Wikstrom; Tomer Nir; Clary B Clish; Bhavapriya Vaitheesvaran; Othon Iliopoulos; Irwin Kurland; Yuval Dor; Ralph Weissleder; Orian S Shirihai; Leif W Ellisen; Joaquin M Espinosa; Raul Mostoslavsky
Journal:  Cell       Date:  2010-01-22       Impact factor: 41.582

10.  Activation of peroxisome proliferator-activated receptor gamma by rosiglitazone increases sirt6 expression and ameliorates hepatic steatosis in rats.

Authors:  Soo Jin Yang; Jung Mook Choi; Seoung Wan Chae; Won Jun Kim; Se Eun Park; Eun Jung Rhee; Won Young Lee; Ki Won Oh; Sung Woo Park; Sun Woo Kim; Cheol-Young Park
Journal:  PLoS One       Date:  2011-02-23       Impact factor: 3.240

View more
  27 in total

Review 1.  SIRT6, a Mammalian Deacylase with Multitasking Abilities.

Authors:  Andrew R Chang; Christina M Ferrer; Raul Mostoslavsky
Journal:  Physiol Rev       Date:  2019-08-22       Impact factor: 37.312

2.  miR-34a inhibits tumorigenesis of NSCLC via targeting SIRT6.

Authors:  Libo Ruan; Jun Chen; Litao Ruan; Anjun Tan; Ping Wang
Journal:  Int J Clin Exp Pathol       Date:  2018-03-01

3.  Inhibition of Sirt6 suppresses tumor growth by inducing G1/S phase arrest in renal cancer cells.

Authors:  Yu Ding; Sisi Wu; Yuwei Huo; Xuemei Chen; Li Chai; Yan Wang; Xiangxiu Wang; Guonian Zhu; Wei Jiang
Journal:  Int J Clin Exp Pathol       Date:  2019-07-01

4.  CXCL5 regulation of proliferation and migration in human non-small cell lung cancer cells.

Authors:  Lin Wang; Lin Shi; Jie Gu; Cheng Zhan; Junjie Xi; Jianyong Ding; Di Ge
Journal:  J Physiol Biochem       Date:  2018-03-10       Impact factor: 4.158

Review 5.  SIRT6: Novel Mechanisms and Links to Aging and Disease.

Authors:  Luisa Tasselli; Wei Zheng; Katrin F Chua
Journal:  Trends Endocrinol Metab       Date:  2016-11-09       Impact factor: 12.015

Review 6.  Association of sirtuins (SIRT1-7) with lung and intestinal diseases.

Authors:  Yuhan Chen; Di Zhou; Yuan Feng; Bingxin Li; Yong Cui; Gang Chen; Ning Li
Journal:  Mol Cell Biochem       Date:  2022-05-20       Impact factor: 3.396

Review 7.  cAMP Signaling in Cancer: A PKA-CREB and EPAC-Centric Approach.

Authors:  Muhammad Bilal Ahmed; Abdullah A A Alghamdi; Salman Ul Islam; Joon-Seok Lee; Young-Sup Lee
Journal:  Cells       Date:  2022-06-24       Impact factor: 7.666

Review 8.  Sirtuin-dependent clock control: new advances in metabolism, aging and cancer.

Authors:  Selma Masri
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2015-11       Impact factor: 4.294

9.  Isoproterenol increases histone deacetylase 6 expression and cell migration by inhibiting ERK signaling via PKA and Epac pathways in human lung cancer cells.

Authors:  Jeong Ah Lim; Yong-Sung Juhnn
Journal:  Exp Mol Med       Date:  2016-01-15       Impact factor: 8.718

Review 10.  A dynamic interface between ubiquitylation and cAMP signaling.

Authors:  Laura Rinaldi; Maria Sepe; Rossella Delle Donne; Antonio Feliciello
Journal:  Front Pharmacol       Date:  2015-09-04       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.